Teduglutide

A Study of Teduglutide in Japanese People With Short Bowel Syndrome

Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients

A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome

Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study

A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older

Pediatric Teduglutide Registry

Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD Patients

A Study of the Gut Barrier and Blood Vessel Inflammation in Individuals With and Without HIV

An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004

Pilot Study to Investigate the Effect of Teduglutide on Temporary Ileostomy Function and Complications

A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult Participants

Plasma Lipoprotein Response to Glucagon-like Peptide-2

Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids

A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302

Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral Support

Teduglutide for Enterocutaneous Fistula (ECF)

Therapeutic Approaches to Malnutrition Enteropathy

Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)

A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021

A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome